Semler Scientific investors file class action over alleged DOJ lawsuit risk.

The Portnoy Law Firm is advising Semler Scientific investors to file a class action lawsuit due to alleged securities fraud. The class action covers investors who bought securities between March 10, 2021 and April 15, 2025. Investors have until October 28, 2025 to file a lead plaintiff motion. The lawsuit is related to Semler's annual report in 2024, which disclosed a risk of a civil False Claims Act lawsuit seeking damages. Investors can contact attorney Lesley F. Portnoy for a complimentary case evaluation and discussion of options for pursuing claims.

New York, September 12, 2025 — Investors who purchased Semler Scientific, Inc. (NASDAQ: SMLR) securities between March 10, 2021, and April 15, 2025, are being advised to file a class action lawsuit due to alleged securities fraud. The law firm Portnoy Law Firm has issued an alert, urging investors to take action.

The class action lawsuit is based on Semler Scientific's annual report for 2024, which disclosed a risk of a civil False Claims Act lawsuit seeking damages. The report stated that the company faced potential legal action from the U.S. Department of Justice (DOJ) regarding claims for reimbursement related to its peripheral artery disease device, QuantaFlo.

Investors who wish to participate in the class action should contact attorney Lesley F. Portnoy for a complimentary case evaluation and discussion of options for pursuing claims. The deadline to file a lead plaintiff motion is October 28, 2025.

Portnoy Law Firm is advising investors to act quickly, as the deadline is approaching. Investors who believe they have suffered losses due to Semler Scientific's alleged securities fraud should contact the firm for more information.

For more details on the class action lawsuit, investors can visit the firm's website or contact attorney Lesley F. Portnoy directly at 332-239-2660 or info@portnoylaw.com.